Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Expanding the phenotypic spectrum of TNFRSF11A-associated dysosteosclerosis: a case with intracranial extramedullary hematopoiesis

Abstract

Dysosteosclerosis (DOS) is a rare sclerosing bone dysplasia characterized by osteosclerosis and platyspondyly. DOS is genetically heterogeneous and causally associated with mutations in three genes, SLC29A3, CSF1R, and TNFRSF11A. TNFRSF11A has been known as the causal gene for osteopetrosis, autosomal recessive 7, and is recently reported to cause DOS in three cases, which show a complex genotype-phenotype relationship. The phenotypic spectrum of TNFRSF11A-associated sclerosing bone dysplasia remains unclear and needs to be characterized further in more cases with molecular genetic diagnosis. Here, we report another TNFRSF11A-associated DOS case with a homozygous missense mutation (p.R129C). The mutation effect is different from the previous three cases, in which truncated or elongated RANK proteins were generated in isoform specific manner, thus enriching our understanding of the genotype-phenotype association in TNFRSF11A-associated sclerosing bone dysplasia. Besides DOS, our case presented with intracranial extramedullary hematopoiesis, which is an extremely rare condition and has not been identified in any other sclerosing bone dysplasias with molecular genetic diagnosis. Our findings provide the fourth case of TNFRSF11A-associated DOS and further expand its phenotypic spectrum.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Elçioglu NH, Vellodi A, Hall CM. Dysosteosclerosis: a report of three new cases and evolution of the radiological findings. J Med Genet. 2002;39:603–7.

    Article  Google Scholar 

  2. Campeau PM, Lu JT, Sule G, Jiang MM, Bae Y, Madan S, et al. Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis. Hum Mol Genet. 2012;21:4904–9.

    Article  CAS  Google Scholar 

  3. Turan S, Mumm S, Gottesman GS, Abali S, Serpil B, Atay Z, et al. Dysosteosclerosis from a unique mutation in SLC29A3. Bone Abstr. 2015;4:97.

    Google Scholar 

  4. Howaldt A, Nampoothiri S, Quell LM, Ozden A, Fischer-Zirnsak B, Collet C, et al. Sclerosing bone dysplasias with hallmarks of dysosteosclerosis in four patients carrying mutations in SLC29A3 and TCIRG1. Bone. 2019;120:495–503.

    Article  CAS  Google Scholar 

  5. Guo L, Bertola DR, Takanohashi A, Saito A, Segawa Y, Yokota T, et al. Bi-Allelic CSF1R mutations cause skeletal dysplasia of Dysosteosclerosis-Pyle disease spectrum and degenerative encephalopathy with brain malformation. Am J Hum Genet. 2019;104:925–35.

    Article  CAS  Google Scholar 

  6. Guo L, Elcioglu NH, Karalar OK, Topkar MO, Wang Z, Sakamoto Y, et al. Dysosteosclerosis is also caused by TNFRSF11A mutation. J Hum Genet. 2018;63:769–74.

    Article  CAS  Google Scholar 

  7. Xue JY, Wang Z, Shinagawa S, Ohashi H, Otomo N, Elcioglu NH, et al. TNFRSF11A-associated dysosteosclerosis: a report of the second case and characterization of the phenotypic spectrum. J Bone Min Res. 2019;34:1873–9.

    Article  CAS  Google Scholar 

  8. Xue JY, Wang Z, Smithson SF, Burren CP, Matsumoto N, Nishimura G, et al. The third case of TNFRSF11A-associated dysosteosclerosis with a mutation producing elongating proteins. J Hum Genet. 2020;9:1–7.

    Google Scholar 

  9. Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, et al. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet. 2008;83:64–76.

    Article  CAS  Google Scholar 

  10. Pangrazio A, Cassani B, Guerrini MM, Crockett JC, Marrella V, Zammataro L, et al. RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations. J Bone Min Res. 2012;27:342–51.

    Article  CAS  Google Scholar 

  11. Sandeep S, Ravikanth R, Philip B. Magnetic resonance imaging findings in intracranial extramedullary hematopoiesis in myelofibrosis with myeloid metaplasia: a case report. Int J Adv Med. 2016;3:1074–6.

    Google Scholar 

  12. Haidar S, Ortiz-Neira C, Shroff M, Gilday D, Blaser S. Intracranial involvement in extramedullary hematopoiesis: case report and review of the literature. Pediatr Radiol. 2005;35:630–4.

    Article  Google Scholar 

  13. Aljerdah SA. Case Report: intracranial Extra-Medullary Hematopoiesis in a Child with Osteopetrosis. Med J Cairo Univ. 2018;86:2507–10.

    Article  Google Scholar 

  14. Liu C, Walter TS, Huang P, Zhang S, Zhu X, Wu Y, et al. Structural and functional insights of RANKL-RANK interaction and signaling. J Immunol. 2010;184:6910–9.

    Article  CAS  Google Scholar 

  15. Ikebuchi Y, Aoki S, Honma M, Hayashi M, Sugamori Y, Khan M, et al. Coupling of bone resorption and formation by RANKL reverse signalling. Nature. 2018;561:195–200.

    Article  CAS  Google Scholar 

  16. Spranger JW, Brill PW, Hall C, Superti-Furga A, Unger S. Bone dysplasias: an atlas of genetic disorders of skeletal development. NewYork: Oxford University Press; 2018.

  17. Xue JY, Ikegawa S, Guo L. Genetic disorders associated with the RANKL/OPG/RANK pathway. J Bone Min Metab. 2020;17:1–9.

    Google Scholar 

  18. Cook G, Sharp RA. Spinal cord compression due to extramedullary haemopoiesis in myelofibrosis. J Clin Pathol. 1994;47:464–5.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Mrs Tomoko Kusadokoro for the technical support. This study is supported by grants from the Japan Society for the Promotion of Science (SI, No. 18H02932; NMi, No JP19H03621). Japan Agency For Medical Research and Development (SI, No. 20bm0804006h and 20ek0109486h; NMa, JP20ek0109486, JP20ek0109301, JP20ek0109348, and JP20kk0205012). CAMS Initiative Fund for Medical Sciences (ZW, 2016-I2M-3-003) and RIKEN Incentive Research Projects (ZW, 201801062228).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shiro Ikegawa or Long Guo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xue, JY., Simsek-Kiper, P.O., Utine, G.E. et al. Expanding the phenotypic spectrum of TNFRSF11A-associated dysosteosclerosis: a case with intracranial extramedullary hematopoiesis. J Hum Genet 66, 607–611 (2021). https://doi.org/10.1038/s10038-020-00891-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-020-00891-w

This article is cited by

Search

Quick links